All In Biotech

Drug Trial Radar · NCT04793295

Study to Investigate Drug-Drug Interaction Between MT-7117 and Test Drugs in Healthy Subjects

A Phase I, Open-Label, Four-Part, Single-Sequence Study to Investigate Drug-Drug Interaction Between MT-7117 and Test Drugs in Healthy Subjects

Last checked: Nov 20, 2026Latest source record: May 15, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

112

Actual

Start

Mar 23, 2021

Primary completion

Feb 4, 2022

Study completion Feb 4, 2022

Sponsor

Lead sponsor
Tanabe Pharma America, Inc.Industry
Sponsor type
Industry
First posted
Mar 11, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Other
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Study is to investigate drug levels in the blood after taking single or multiple doses of the study drug, MT-7117, in healthy adults when taken together with another drug. This study will also look at the safety and the body's ability to tolerate MT-7117

Conditions

  • Healthy Subjects

Interventions

  • MT-7117Drug

    MT-7117

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum observed plasma concentration (Cmax)Time frame: Part 1 Day 1 to Day 19, Part 2 Day 1 to Day 15, Part 3 Day 1 to Day 17, Part 4 Day 1 to Day 13
  2. Area under the plasma concentration-time curve (AUC) from time zero to infinity (AUC0-∞)Time frame: Part 1 Day 1 to Day 19, Part 2 Day 1 to Day 15, Part 3 Day 1 to Day 17, Part 4 Day 1 to Day 13
  3. AUC from time zero to the last measurable concentration (AUC0-last)Time frame: Part 1 Day 1 to Day 19, Part 2 Day 1 to Day 15, Part 3 Day 1 to Day 17, Part 4 Day 1 to Day 13

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Advanced Pharma CR, LLC

    Miami, Florida

  • Worldwide Clinical Trials

    San Antonio, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.